Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
NEW YORK (
) -- The ex-dividend date for
) is tomorrow, September 27, 2012. Owners of shares as of market close today will be eligible for a dividend of 17 cents per share. At a price of $63.13 as of 9:31 a.m. ET, the dividend yield is 1.1%.
The average volume for Quest has been 859,300 shares per day over the past 30 days. Quest has a market cap of $9.99 billion and is part of the
industry. Shares are up 8.6% year to date as of the close of trading on Tuesday.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company has a P/E ratio of 14.5, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
TheStreet Ratings rates Quest as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, notable return on equity and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!
Free download now